Literature DB >> 12168141

[Sonographic diagnosis of congenital dacryocystocele].

B Schlenck1, K Unsinn, T Geley, A Schön, I Gassner.   

Abstract

AIM: Congenital obstruction of the nasolacrimal drainage system occurs quite commonly. The reason is usually an impaired canalization at the distal end of the nasolacrimal duct with a residual membrane between the duct and the nasal cavity. Dacryocystocele is believed to result from a concomitant upper and lower system obstruction, causing fluid accumulation and distension of the lacrimal sac. The patient presents at birth with a tense, blue-grey swelling located just below the medial canthal tendon. The differential diagnosis for dacryocystocele includes haemangioma, encephalocele, glioma, dermoid cysts and malignant processes.
MATERIAL AND METHODS: We demonstrate five typical cases to describe the sonographic features of dacryocystocele.
RESULTS: Ultrasound is a simple, straight forward and gentle method to reliably distinguish dacryocystoceles from other pathologies. A sedation of the patient is not necessary. The sonographic appearance of a cystic mass medial and inferior of the orbit communicating with the dilated nasolacrimal duct as well as the typical content of fluid and debris was diagnostic of a nasolacrimal mucocele or dacryocystocele. Other more invasive imaging techniques as CT-scans and MRI are of benefit only if there is any doubt about the diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12168141     DOI: 10.1055/s-2002-33156

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  2 in total

1.  [Treatment-refractory epiphora after dacryocystorhinostomy-role of imaging and histopathology].

Authors:  Anne-Cécile Vandebroek; Annekatrin Rickmann; Karl Boden; Gesine Szurman; Victoria Bozzato; Berthold Seitz; Fabian N Fries
Journal:  Ophthalmologie       Date:  2022-06-15

2.  Congenital dacryocystocele: diagnosis and treatment.

Authors:  S Cavazza; G L Laffi; L Lodi; G Tassinari; D Dall'Olio
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-12       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.